Skip to main content

FDA: Asbestos Traces Found in Claire's & Justice Products

FDA: Asbestos Traces Found in Claire's & Justice Products

FDA: Asbestos Traces Found in Claire's & Justice Products

Introduction

The U.S. Food and Drug Administration (FDA) confirmed the presence of asbestos in product samples taken from Claire’s and Justice stores and advised consumers not to use talc-based cosmetic products.

The FDA issued a safety alert for three of Claire's products (Eye Shadows, Compact Powder, and Contour Palette) after they were found to be contaminated with tremolite asbestos. Asbestos traces were also detected in one of the product sold by Justice which was recalled in 2017. On March 11, Claire's announced a voluntary recall of the above-mentioned products, which were put up on sale between October 2016 and March 2019. They have been taken out of the marketplace as of now, and the FDA warned consumers to discontinue using those products and return them to Claire's for a full refund. Claire's issued a public notice that said the company had taken out three of its cosmetic products after the Occupational Safety and Health Administration and AMA Analytical Services conducted product testing. The company also vowed to remove any talc-based cosmetic product remaining in their store.

Even though the FDA has not received any reports of illness due to these cosmetics, talc-based products like J&J’s Baby Powder and Shower-to-Shower have been in trouble since decades for causing harmful side-effects including mesothelioma and ovarian cancer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!